A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults
Clinical trial NCT05627258 · COMPLETED
Trial details
- NCT number
- NCT05627258
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2024-07-17
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.